Donald Joseph
And finally this week, KaloBios Pharmaceuticals has appointed Donald Joseph as its new Chief Legal Officer.
Having served as general counsel corporate secretary and in other senior management roles at biopharmaceutical companies, including Abgenix and Renovis, Joseph’s “primary therapeutic areas of experience, which include oncology, infectious diseases, and antibody technology, are directly relevant to KaloBios' own pipeline of patient-targeted, first-in-class monoclonal antibodies,” according to David Pritchard, CEO.
